Tech Company Financing Transactions
Collplant Funding Round
Collplant, operating out of Ness Ziona, secured $2.5 million from Docor International Management and Pontifax Fund.
Transaction Overview
Company Name
Announced On
4/13/2007
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Pinhas Sapir St.
Ness Ziona, 74140
Israel
Ness Ziona, 74140
Israel
Phone
Website
Email Address
Overview
CollPlant is involved in the development and commercialization of proteins produced in its plant expression and production system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yehiel Tal
Chief Financial Officer
Eran Rotem
Chief Operating Officer
Ilana Belzar
Chief Scientific Officer
Oded Shoseyov
VP - R & D
Nadav Orr
VP - Regulatory Affairs
Philippe Bensimon
Browse more venture capital transactions:
Prev: 4/13/2007: StageMark venture capital transaction
Next: 4/13/2007: TransMedics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs